SDBG
The Site-Directed Bone Growth project comprises two inventions: the first invention is designed to facilitate and accelerate bone growth in precisely targeted locations in the body using a simple surgical procedure that can be performed with minimal intervention on an outpatient basis in combination with one or more therapeutic compounds. The second invention covers unique devices that could be used to facilitate bone repair or to create novel prostheses. Both inventions were conceived in collaboration with Dr. Agnès Vignery, Associate Professor of Orthopaedic Surgery at Yale School of Medicine. Patent applications have been filed individually for the two inventions.
Unigene is currently sponsoring developmental research activities at Yale University and is assembling an internationally distinguished group of orthopedic physicians and surgeons with whom it will evaluate the technologies in animal and human studies.
The following is a quote from Dr. Donlin M. Long, M.D., Ph.D., Distinguished Service Professor of Neurosurgery at the Johns Hopkins University School of Medicine.
"The Unigene/Yale techniques have the potential to provide a dramatic new treatment for these problems. The ability to facilitate bone growth is of great practical importance for the treatment of spinal fractures, especially in the elderly. Compression fractures are common and can be very painful. Growing new bone with this invention offers potential relief for the large number of patients who cannot be helped by any treatment now in use. Improved bone healing can improve outcomes from many spinal surgeries and can reduce the incidence of pain and prolonged disability."
-- Unigene Laboratories, Inc. press release September 19, 2005, Unigene and Yale University Invent Technologies to Build New Bone
| 
